Ageing and Neurodegeneration

Ageing and neurodegeneration are intricately linked processes that profoundly influence human health and quality of life. With advancing age comes an elevated susceptibility to neurodegenerative conditions like Alzheimer's, Parkinson's, and Huntington's diseases, which impose significant cognitive and motor impairments, ultimately diminishing independence. A pivotal mechanism in this progression is the accumulation of abnormal protein aggregates within neurons, disrupting cellular function and precipitating cell death. For instance, in Alzheimer's, beta-amyloid plaques and tau tangles disrupt neuronal communication, leading to memory loss and cognitive decline. Moreover, oxidative stress and inflammation contribute substantially to both ageing and neurodegeneration, as cells accrue damage from reactive oxygen species over time, rendering them more vulnerable to neurodegenerative processes. Concurrently, chronic brain inflammation exacerbates neuronal damage and hastens disease progression. Genetic predispositions also play a crucial role, with certain mutations heightening susceptibility to neurodegenerative diseases by impairing protein processing or cellular maintenance mechanisms. Understanding this intricate interplay is paramount for devising effective interventions and treatments. Research into lifestyle factors such as diet, exercise, and cognitive stimulation holds promise in attenuating cognitive decline and reducing the risk of neurodegenerative diseases in ageing populations. Additionally, targeted therapies aimed at clearing abnormal protein aggregates or modulating inflammatory processes offer hope for enhancing the quality of life for ageing individuals grappling with neurodegeneration.